Preference for hip protectors among older adults at high risk for osteoporotic fractures.
Fraenkel L, Gulanski B, Wittink DR. Preference for hip protectors among older adults at high risk for osteoporotic fractures. The Journal Of Rheumatology 2006, 33: 2064-8. PMID: 17014021, PMCID: PMC1615711.Peer-Reviewed Original ResearchConceptsWeekly oral bisphosphonatesHip protectorsHigh riskOral bisphosphonatesHip fractureTreatment preferencesHealth problemsOlder adultsCommunity-dwelling older adultsCurrent bisphosphonate usersNonpharmacologic treatment approachesOsteoporotic hip fracturesMost health problemsType of treatmentBisphosphonate usersWeekly bisphosphonatesOsteoporotic fracturesFuture trialsDiscrete choice questionnaireTreatment choiceTreatment approachesBisphosphonatesStudy 57Absolute reductionPrescription drugsPatient willingness to take teriparatide
Fraenkel L, Gulanski B, Wittink D. Patient willingness to take teriparatide. Patient Education And Counseling 2006, 65: 237-244. PMID: 16965888, PMCID: PMC1769517, DOI: 10.1016/j.pec.2006.08.004.Peer-Reviewed Original ResearchMeSH KeywordsAbsorptiometry, PhotonAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsChoice BehaviorConnecticutDrug Administration ScheduleFemaleFractures, BoneHealth Knowledge, Attitudes, PracticeHealth Services Needs and DemandHumansInjections, SubcutaneousMiddle AgedMultivariate AnalysisOsteoporosis, PostmenopausalPatient Acceptance of Health CarePostmenopauseRisk AssessmentSocioeconomic FactorsSurveys and QuestionnairesTeriparatideWomenConceptsDaily subcutaneous injectionsTreatment preferencesSubcutaneous injectionFuture fracturesMost womenAbsolute fracture riskTreatment of osteoporosisNovel treatment approachesConjoint analysis questionnairePostmenopausal womenAdaptive conjoint analysis questionnaireDaily injectionsPoor adherenceEfficacy advantageFracture riskPatients' willingnessClinical studiesAge 71Bone densitometryEffective treatmentNumber of subjectsTreatment approachesT-scoreOlder adultsWomen